Neuron23
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Based based in San Francisco Bay Area, West Coast, Western US, Neuron23 works in health care, medical, pharmaceutical, founded in 2018.
Within the health care, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in San Francisco Bay Area, West Coast, Western US.
Directory data places it at the Series_C stage.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $213.5M.
| Sector | Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Founded | 2018 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $213,500,000 |
Website: neuron23.com
Sign in to view the contact information we hold for Neuron23.
Create a free account
Create a free account